Sir,
We have read with great interest the article by Korkeila et al (2009) ‘Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer’ in a recent issue of the British Journal of Cancer. As the authors rightly state, CA-IX has been found to be of clinical value in different tumour types. The authors, however, state that their study was ‘designed to assess the prognostic and predictive value of CA-IX in rectal cancer treated by either short or long course of radiotherapy’. Although this might be the case, their data analysis does not support this statement.
The prognostic value of CA-IX, if present, cannot be deduced from the applied patient cohort, as all patients received radio- and/or chemotherapy. A pure prognostic factor can only be detected in an untreated patient population. CA-IX is also known to be strongly induced by hypoxia through HIF1a upregulation (Lal et al, 2001). The hypoxic phenotype that is represented by the high expression levels of CA-IX is very likely to cause a predictive value of CA-IX, predicting in this case resistance to radiotherapy and possibly also chemotherapy. Earlier, we have found CA-IX to be predictive for different adjuvant treatments in breast cancer (Span et al, 2003).
On the other hand, the authors also describe a control group that would seem to have received no neoadjuvant chemo- or radiotherapy. If these patients also did not receive adjuvant therapy, which is regrettably unclear from the paper, the authors should be able to determine whether the clinical value of CA-IX is similar in treated and untreated rectal cancer patients. This could add valuable information to this subject and would warrant publication.
In our opinion, the results shown so far only allow the statement ‘Expression of Carbonic Anhydrase IX suggests poor response to therapy in rectal cancer’.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Korkeila E, Talvinen K, Jaakkola PM, Minn H, Syrjänen K, Sundström J, Pyrhönen S (2009) Expression of carbonic anhydrase IX suggests poor outcome in rectal cancer. Br J Cancer 100: 874–880
Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ, Riggins GJ (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93: 1337–1343
Span PN, Bussink J, Manders P, Beex LV, Sweep CG (2003) Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. Br J Cancer 89: 271–276
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Span, P., Nagtegaal, I. & Bussink, J. Expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer. Br J Cancer 101, 372 (2009). https://doi.org/10.1038/sj.bjc.6605090
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6605090
This article is cited by
-
Reply: expression of carbonic anhydrase IX suggests poor response to therapy in rectal cancer
British Journal of Cancer (2009)